These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 8668605

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.
    Packer M.
    Circulation; 1989 Dec; 80(6 Suppl):IV59-67. PubMed ID: 2688986
    [Abstract] [Full Text] [Related]

  • 3. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT.
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [Abstract] [Full Text] [Related]

  • 4. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
    Packer M, Kessler PD, Lee WH.
    Circulation; 1987 Jun; 75(6 Pt 2):V56-64. PubMed ID: 3552317
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
    White CM.
    Conn Med; 1997 Oct; 61(10):659-61. PubMed ID: 9375452
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Calcium channel blockers in heart failure].
    Hole T, Dickstein K, Gundersen T, Kjekshus J, Myhre ES, Rønnevik PK, Westheim AS.
    Tidsskr Nor Laegeforen; 1997 Jun 20; 117(16):2329-32. PubMed ID: 9265278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Calcium antagonists in heart failure.
    Klugmann S, Salvi A, Camerini F.
    Herz; 1983 Apr 20; 8(2):88-92. PubMed ID: 6852766
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ca channel blocker and heart failure].
    Kinugawa S, Tsutsui H.
    Clin Calcium; 2005 Oct 20; 15(10):1615-22. PubMed ID: 16199906
    [Abstract] [Full Text] [Related]

  • 14. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
    Gattis W, O'Connor CM.
    Drugs; 2000 Oct 20; 59 Spec No 2():17-24. PubMed ID: 11002855
    [Abstract] [Full Text] [Related]

  • 15. [Calcium antagonists and heart failure. Critical review of the literature].
    Devigili G.
    Minerva Cardioangiol; 1994 Apr 20; 42(4):177-89. PubMed ID: 8058185
    [Abstract] [Full Text] [Related]

  • 16. Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.
    Metra M, Nodari S, D'Aloia A, Madureri A, Rosselli F, Bontempi L, Zanini R, Dei Cas L.
    Eur Heart J; 1998 Feb 20; 19 Suppl B():B25-35. PubMed ID: 9519349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M, Edelmann F, Knapp M, Schön S, Schwencke C, Simonis G, Borst M, Weinbrenner C, Strasser RH.
    Int J Cardiol; 2009 Feb 20; 132(2):248-56. PubMed ID: 18579230
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ, Dietz R.
    Z Kardiol; 1997 Jan 20; 86(1):1-8. PubMed ID: 9133118
    [Abstract] [Full Text] [Related]

  • 20. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
    Mahé I, Chassany O, Grenard AS, Caulin C, Bergmann JF.
    Am J Cardiovasc Drugs; 2003 Jan 20; 3(1):33-41. PubMed ID: 14727944
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.